FDA Approves Genentech ’s Actemra for the Treatment of COVID-19 in Hospitalized Adults

South San Francisco, CA -- December 21, 2022 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Actemra® (tocilizumab)...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news